Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy

被引:103
作者
Langendijk, JA
Slotman, BJ
van der Waal, I
Doornaert, P
Berkof, J
Leemans, CR
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Radiat Oncol, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Dept Maxillary Surg, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Med Ctr, Dept Otolaryngol Head & Neck Surg, Amsterdam, Netherlands
关键词
head and neck carcinoma; radiotherapy; prognostic factors; overall treatment time;
D O I
10.1002/cncr.21340
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. The objective of this study was to define different prognostic groups with regard to locoregional control (LRC) derived from recursive partitioning analysis (RPA). METHODS. Eight hundred one patients with squamous cell head and neck carcinoma underwent with primary surgery and received postoperative radiotherapy. For the definition of prognostic groups, the method of classification and regression trees was performed, including a large number of well known prognostic factors. RESULTS. The final model was composed of six prognostic factors for LRC, resulting in seven terminal nodes. RPA Class I (intermediate risk) consisted of 381 patients who had no N3 lymph nodes, free surgical margins (> 5 mm), and no extranodal spread (ENS). RPA Class 11 (high risk) consisted of 189 patients who had 1 positive lymph node with ENS or had T1, T2, or T4 tumors with close or positive surgical margins. RPA Class III (very high risk) consisted of 231 patients who had a N3 neck, 2 positive lymph nodes with ENS, or a T3 tumor with close or positive surgical margins. The 5-year LRC rate was 88%, 73% and 58%, in RPA Class 1, 11, and III, respectively (P < 0.0001). The hazard ratio (HR) relative to RPA Class I was 2.3 (95% confidence interval [95%CI], 1.5-3.6) for RPA Class II and 4.2 (95%CI, 2.8-6.1) for RPA Class III. CONCLUSIONS. The RPA classification scheme studied allowed for the clear definition of three prognostic groups with regard to LRC and OS. These groups may be useful in the design of future prospective, randomized studies investigating new treatment modalities.
引用
收藏
页码:1408 / 1417
页数:10
相关论文
共 50 条
  • [31] Salvage surgery for advanced stage head and neck squamous cell carcinoma following radiotherapy or chemoradiation
    Joris B. W. Elbers
    Lars I. Veldhuis
    Patrick A. Bhairosing
    Ludi E. Smeele
    Katarzyna Jóźwiak
    Michiel W. M. van den Brekel
    Marcel Verheij
    Abrahim Al-Mamgani
    Charlotte L. Zuur
    European Archives of Oto-Rhino-Laryngology, 2019, 276 : 647 - 655
  • [32] Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy
    Manyam, Bindu V.
    Gastman, Brian
    Zhang, Alexandra Y.
    Reddy, Chandana A.
    Burkey, Brian B.
    Scharpf, Joseph
    Alam, Daniel S.
    Fritz, Michael A.
    Vidimos, Allison T.
    Koyfman, Shlomo A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (02) : 221 - 227
  • [33] Postoperative Clinical Radiosensitivity in Patients With Fanconi Anemia and Head and Neck Squamous Cell Carcinoma
    Birkeland, Andrew C.
    Auerbach, Arleen D.
    Sanborn, Erica
    Parashar, Bhupesh
    Kuhel, William I.
    Chandrasekharappa, Settara C.
    Smogorzewska, Agata
    Kutler, David I.
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2011, 137 (09) : 930 - 934
  • [34] Effect of smoking on oxygen delivery and outcome in patients treated with radiotherapy for head and neck squamous cell carcinoma - A prospective study
    Hoff, Camilla Molich
    Grau, Cai
    Overgaard, Jens
    RADIOTHERAPY AND ONCOLOGY, 2012, 103 (01) : 38 - 44
  • [35] Timing factors as prognostic variables in patients with head and neck squamous cell carcinoma treated with adjuvant radiotherapy: a literature review
    Franco, Rejane
    Marta, Gustavo Nader
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 (03): : 380 - 384
  • [36] Acute toxicity in 14 patients with locally advanced head and neck squamous cell carcinoma treated with concurrent cetuximab and radiotherapy
    Valeriani, M.
    Muni, R.
    Osti, M. F.
    De Sanctis, V.
    Minniti, G.
    Ardito, F.
    Enrici, R. Maurizi
    RADIOLOGIA MEDICA, 2012, 117 (01): : 125 - 132
  • [37] Time from surgery to commencing adjuvant radiotherapy does not affect survival in patients with head and neck squamous cell carcinoma
    Price, James M.
    Ferrera, Alexandra
    Garcez, Kate
    Hughes, Christopher
    Lee, LipWai
    Motamedi-Ghahfarokhi, Golnoosh
    Price, Gareth
    West, Catharine
    Thomson, David
    RADIOTHERAPY AND ONCOLOGY, 2024, 192 : S238 - S241
  • [38] Influence of time between surgery and adjuvant radiotherapy on prognosis for patients with head and neck squamous cell carcinoma: A systematic review
    Sun, Kaiyuan
    Tan, Jia Yan
    Thomson, Peter James
    Choi, Siu-Wai
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2023, 45 (08): : 2108 - 2119
  • [39] Routine feasibility of postoperative chemoradiotherapy in head and neck squamous cell carcinoma at high risk of recurrence
    Humbert, M.
    De La Losa, M.
    Gery, B.
    Florescu, C.
    Thariat, J.
    Rambeau, A.
    EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES, 2020, 137 (05) : 371 - 375
  • [40] Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma
    Kubota, Hikaru
    Miyawaki, Daisuke
    Mukumoto, Naritoshi
    Ishihara, Takeaki
    Matsumura, Megumi
    Hasegawa, Takumi
    Akashi, Masaya
    Kiyota, Naomi
    Shinomiya, Hirotaka
    Teshima, Masanori
    Nibu, Ken-ichi
    Sasaki, Ryohei
    RADIATION ONCOLOGY, 2021, 16 (01)